Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 15, Pages 3847
Publisher
MDPI AG
Online
2021-07-31
DOI
10.3390/cancers13153847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression
- (2021) Jia-Jia Zhang et al. DISEASE MARKERS
- Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
- (2021) Bashir Lawal et al. Biomedicines
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multi-Omics Data Analysis of Gene Expressions and Alterations, Cancer-Associated Fibroblast and Immune Infiltrations, Reveals the Onco-Immune Prognostic Relevance of STAT3/CDK2/4/6 in Human Malignancies
- (2021) Bashir Lawal et al. Cancers
- Integrated analysis and identification of nine-gene signature associated to oral squamous cell carcinoma pathogenesis
- (2021) Monika Yadav et al. 3 Biotech
- mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
- (2021) Bashir Lawal et al. Frontiers in Oncology
- In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
- (2021) Harshita Nivrutti Khedkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
- (2020) Amit S. Choudhari et al. Frontiers in Pharmacology
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
- (2020) Jih-Chin Lee et al. Cancers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ovatodiolide Inhibits the Oncogenicity and Cancer Stem Cell-like Phenotype of Glioblastoma Cells, as well as Potentiate the Anticancer Effect of Temozolomide
- (2019) Yu-kai Su et al. PHYTOMEDICINE
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Ovatodiolides: Scalable Protection-free Syntheses, Configuration Determination and Biological Evaluation against Hepatic Cancer Stem Cells
- (2019) Junhong Xiang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients
- (2019) János T. Fekete et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer
- (2019) Xin Yan et al. Frontiers in Genetics
- Ovatodiolide suppresses inflammatory response in BEAS-2B cells by regulating the CREB/AQP5 pathway, and sensitizes nasopharyngeal carcinoma cells to radiation therapy
- (2019) Shao-Cheng Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
- (2019) Tom J. Harryvan et al. Journal of Clinical Medicine
- Molecular docking studies on the interaction of NCI anticancer analogues with human Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit
- (2019) David Ebuka Arthur et al. JOURNAL OF KING SAUD UNIVERSITY SCIENCE
- Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
- (2019) Jia-Hong Chen et al. Cancers
- GSCALite: a web server for gene set cancer analysis
- (2018) Chun-Jie Liu et al. BIOINFORMATICS
- Investigation of Ovatodiolide, a Macrocyclic Diterpenoid, as a potential inhibitor of Oral Cancer Stem-Like Cells Properties via the Inhibition of the JAK2/STAT3/JARID1B Signal Circuit
- (2018) Chun-Shu Lin et al. PHYTOMEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
- (2017) Yan-Jiun Huang et al. Journal of Hematology & Oncology
- Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
- (2016) Marco Demaria et al. Cancer Discovery
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
- (2016) H. Raza Ali et al. PLOS MEDICINE
- Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity
- (2015) Oluwaseun Adebayo Bamodu et al. CANCER LETTERS
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Presentation and management of docetaxel-related adverse effects in patients with breast cancer
- (2014) Maria Ho et al. Cancer Management and Research
- Ovatodiolide Targetsβ-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma
- (2013) Jar-Yi Ho et al. Evidence-based Complementary and Alternative Medicine
- Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
- (2012) Xuan-Yu Meng et al. Current Computer-Aided Drug Design
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
- (2012) Marcus D Hanwell et al. Journal of Cheminformatics
- Hydrogen Bonding Penalty upon Ligand Binding
- (2011) Hongtao Zhao et al. PLoS One
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Bioactive Cembrane Diterpenoids ofAnisomeles indica
- (2008) Yu-Li Chen et al. JOURNAL OF NATURAL PRODUCTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now